Showing 101 - 120 results of 63,908 for search '(( significant sup increase ) OR ( significant ((step decrease) OR (we decrease)) ))', query time: 0.60s Refine Results
  1. 101
  2. 102
  3. 103
  4. 104
  5. 105

    Effects of time on delivery of SYTOX<sup>TM</sup> on corona treatment at ambient temperature. by Molly A. Skinner (17200146)

    Published 2023
    “…<p>The * indicates statistical significance in the increase of the delivery of SYTOX<sup>TM</sup>. …”
  6. 106
  7. 107

    Proliferation defects in Opa1 depleted type II NB lineages are suppressed by overexpression of Drp1<sup>SD</sup>. by Dnyanesh Dubal (12085942)

    Published 2022
    “…Analysis of mitotic type II NBs per brain lobe (C) in mCherry RNAi (10 brain lobes), Drp1<sup>SD</sup> (6), <i>opa1</i> (8), Drp1<sup>SD</sup>;<i>opa1</i> RNAi (10), <i>marf</i> RNAi (12), Drp1<sup>SD</sup>;<i>marf</i> RNAi (10). …”
  8. 108
  9. 109
  10. 110
  11. 111
  12. 112
  13. 113

    S1 Data - by Li-Min Wang (783263)

    Published 2024
    Subjects:
  14. 114
  15. 115
  16. 116
  17. 117
  18. 118
  19. 119

    Neulasta<sup>®</sup> and Stimufend<sup>®</sup> formulations. by Alison Sykes (19942577)

    Published 2024
    “…There are no clinically significant differences between Stimufend<sup>®</sup> and Neulasta<sup>®</sup>, which was confirmed by the marketing approval for Stimufend<sup>®</sup> by the Food and Drug Administration and the European Medicines Agency.…”
  20. 120